# Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

> **NCT00955357** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 461 (actual)

## Conditions studied

- Partial Epilepsies

## Interventions

- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT00955357
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2013-04
- **Final completion:** 2013-08
- **Target enrollment:** 461 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955357, "Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00955357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*